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Abstract
Background: Nursing home residents are frequently affected by joint contractures, which impacts their
participation and daily activities. A complex intervention, the Participation Enabling Care in Nursing (PECAN), was
previously developed and pilot tested to address their needs. Its effectiveness and safety will be evaluated in the
present study.
Methods/design: This multicentre cluster-randomised controlled trial will be conducted in 32 nursing homes
spread over two regions of Germany. A total of 578 residents over 65 years old with joint contractures will be
included. To compare the effect of the PECAN intervention with optimised standard care (usual care and an
information session), randomisation will take place at a cluster level.
The individually tailored intervention was designed using the biopsychosocial model in the International
Classification of Functioning, Disability and Health (ICF) to reduce activity limitations and participation restrictions
resulting from existing joint contractures by addressing barriers and by strengthening supportive factors on an
individual level and an organisational level.
The implementation strategy comprises a facilitators’ workshop, a peer mentoring approach including a peer
mentor visit and telephone peer counselling, an in-house information event, an information session for the nursing
team and a training session on collegial consultation for the facilitators. The in-house information event will also
take place in the nursing homes of the control group. The primary outcome is the residents’ participation and
activities after 12 months of follow-up as assessed using the PaArticular Scales. The secondary outcome is the
residents’ quality of life. A cost-effectiveness analysis (costs per additional resident who experienced a decrease of
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ten points in the participation or activities subscale of the PaArticular Scales) and a cost–utility analysis (costs per
additional quality adjusted life year) will be conducted. We will investigate barriers and facilitators in a
comprehensive process evaluation.
Discussion: We expect a clinically relevant improvement of participation and activities in residents with joint
contractures. Our findings will provide important insights regarding participation in the situation of the affected
individuals.
Trial registration: DRKS, DRKS00015185. Registered on 1 August 2018. Universal Trial Number U1111–1218-1555.
Registered on 26 July 2018.
Keywords: Joint contractures; Participation; Activities; Nursing homes; International Classification of Functioning,
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Background
Joint contractures are common in older frail people in
geriatric care and are associated with pain, increased fall
risk and decreased functional ability [1–3]. Hence, af-
fected individuals experience limitations in their capacity
to perform daily activities and to participate in social life,
and may thus, require nursing care [1, 4]. Recent re-
search has shown that activity limitations and participa-
tion restrictions in self-care, mobility or leisure activities
are the most relevant aspects from the viewpoint both of
older people with contractures living in nursing homes
or in the community and of health-care experts [4–7].
Despite that, the structural impairment in terms of range
of motion of the affected joint is still the most frequently
reported outcome measure in clinical studies on joint
contractures [8–10]. The number of older individuals af-
fected varies because there is no standardised definition
of joint contractures, the diagnostic criteria differ, and
settings and populations vary [11]. To address and im-
prove the living situation of older people with joint con-
tractures in geriatric care, we carefully planned a set of
research activities using the biopsychosocial model of
the World Health Organization’s International Classifi-
cation of Functioning, Disability and Health (ICF) [12].
The first project included the identification of aspects
related to functioning and disability of those affected to
develop a standardised instrument for assessing the im-
pact of joint contractures [4–8, 11, 13–17]. Based on the
findings of the first project, we developed and piloted
the complex intervention Participation Enabling Care in
Nursing (PECAN) to improve participation and activities
in nursing home residents with joint contractures [10,
18, 19]. Methodologically, we follow the UK Medical Re-
search Council (MRC) framework [20] for the systematic
development and evaluation of complex interventions.
The MRC framework has four key steps: (1) the develop-
ment of the complex intervention based on the best
available evidence, (2) an assessment of its feasibility, (3)
an evaluation of its effectiveness and (4) its wider
implementation [20]. We covered the first two steps in
our previous studies, and the third step is the subject of
this trial.
Objectives
The present study aims to evaluate the PECAN inter-
vention by assessing its effectiveness in improving the
participation and activities in nursing home residents
with joint contractures compared to a control group re-
ceiving optimised standard care, which includes an infor-
mation session about joint contractures in addition to
their usual care. We will assess activities and participa-
tion as the primary outcome measures using the sub-
scales of a previously developed, standardised ICF-based
instrument [17]. To understand the change process, we
plan to investigate facilitating and impeding aspects of
the implementation by accompanying the trial with a
comprehensive process evaluation. Additionally, we will
assess the cost-effectiveness (costs per additional resi-
dent who experienced a decrease of ten points on the
participation or activities subscale of the PaArticular
Scales) and the cost–utility [costs per additional quality
adjusted life year (QALY)] by conducting a health eco-
nomic evaluation alongside the controlled trial.
Methods/design
Design
The study is a multicentre cluster-randomised controlled
trial (c-RCT) with two parallel groups and a 1-year inter-
vention period, with 578 residents in total (see Fig. 1).
An intervention group with 16 nursing homes will re-
ceive the PECAN intervention and a control group with
16 nursing homes will receive optimised standard care,
i.e. participants will receive information in the form of a
presentation concerning the general aspects of joint
contractures in geriatric care. Randomisation will be
performed 1:1 on a cluster level. Outcome assessments
will be performed at baseline with follow-ups at 6 and
12months.
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Participants and recruitment
Sample size calculation
The study uses a composite primary outcome with two
components. To avoid a false positive outcome rate above
5% (significance level), we apply a Bonferroni correction on
each of the two components and choose the component-
wise significance level as 2.5% (0.05/2 = 0.025). Based on
the data from a pilot study, we consider both components
as distributional comparable, assuming that both have
the same variability. Therefore, the sample size consid-
erations for each component follow the same argu-
ments. Thus, it is sufficient to compute an explicit
sample size for one component.
Using the experience of the pilot study (publication in
preparation), recruitment of 15 to 20 individuals per
cluster is feasible. Thus, the sample size calculation as-
sumed a fixed cluster size of 15 individuals and a free
number of clusters. Using pilot data, the intraclass cor-
relation coefficient was estimated at 0.38. This resulted
in an inflation factor of (1 + (15 – 1) × 0.38) = 6.32. The
subscale variance observed in the pilot study was about
200 (standard deviation 14.14); the effect difference for
the participation subscale between the standard and
intervention groups was assumed to be 10 at t2. The size
of one group in this c-RCT is n = 241 (38 × 6.32) if the
test is two-sided on a significance level of 2.5% and with
a power of 80%. This results in a total of 16 clusters per
study group (241 / 15 = 16.1). To compensate for indi-
viduals terminating the study early due to death or mov-
ing, 15% more individuals will be included in the study,
resulting in 30 clusters with a cluster size of 18
individuals and two clusters with 19 individuals, the total
study size being 578 individuals.
Current experience shows that a few clusters will pos-
sibly fail to recruit the necessary number of participants.
In this case, we will recruit more participants in other
clusters to compensate for this. To maintain the statis-
tical power of the study, the following rule will be ap-
plied: number of participants to be additionally recruited
in other clusters = 1.5 × number of participants that
some clusters fail to recruit.
Setting and eligibility criteria
The study will be performed in nursing homes in the
German regions of south-eastern Bavaria and
Saxony-Anhalt. The clusters are defined as nursing
homes. We will include nursing homes in which at least
18 residents are affected by joint contractures. On the
individual level, we will include nursing home residents
aged 65 or older with present joint contractures in major
joints that affect their daily life, who are likely to re-
spond to the intervention, who can be mobilised into a
Fig. 1 Flow of the clusters and participants through the trial
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sitting position, and who are able to understand and
speak German. The joint contractures will be diagnosed
by a physician, a skilled nurse or a physical or occupa-
tional therapist. In this study, they are defined as restricted
joint mobility in at least one major joint (shoulder, elbow,
wrist, hip, knee, or ankle). We will exclude nursing home
residents receiving end-of-life care with limited life
expectancy due to an advanced disease with a poor prog-
nosis, and residents with congenital or idiopathic contrac-
tures i.e. Dupuytren’s contractures, plantar fibromatosis,
and burn scar and other scar contractures.
Recruitment of clusters and study participants
Nursing homes will be recruited from convenience
samples of interested or existing cooperation partners
and from nursing home registers in each study region.
They will be invited to participate in the study via elec-
tronic mail followed by a telephone call. The research
staff will present the study to interested staff members
on site and provide them with detailed information.
Members of the advisory committees in the nursing
homes will be included in all study activities as required
by regional legislation.
After the director of the nursing home has provided
written informed consent, the nursing home will be
enrolled in the study. The head nurse will then identify
eligible residents, and will supply them and, for cogni-
tively impaired residents, also their legal guardians, with
oral and written information about the study. Re-
searchers from the study centres will be available for
questions or to provide additional information in person
or by phone. Eligible residents will then be reviewed by
the management staff together with the research teams
to ensure recruitment is standardised and to avoid het-
erogeneity in the sample. Subsequently, residents found
to be suitable will be invited to participate in the study
and informed consent will be obtained either from the
resident or their legal guardian by the nursing home
management. Consent can be withdrawn by residents
and nursing homes at any time without stating a reason
and without any disadvantages ensuing for either party.
Randomisation and allocation
Randomisation will be performed using stratified blocks.
To ensure the intervention groups are balanced with re-
spect to the location of the nursing homes, block ran-
domisation will be performed taking two strata into
account: (1) Halle (Saale) and (2) Rosenheim. Selection
bias can be a problem in c-RCTs if participants are re-
cruited after a cluster allocation has been implemented.
Therefore, all clusters and participants will be recruited
and assessed prior to randomisation. The clusters will be
randomised by independent biostatisticians responsible
for biometric supervision (UM and LL). Generating,
operating and controlling the randomisation will follow
the standard operating procedures of the biostatisticians’
institution and will be carried out by professionals who
are not involved in trial activities at the nursing homes.
Each of the nursing homes will be informed about its
intervention allocation by fax by an independent data
manager. Subsequently, the data manager will inform the
study centres in Halle (Saale) and Rosenheim via fax about
the allocation.
Blinding
Due to the characteristics of the intervention, it is not
possible to blind the nursing staff, the nursing home res-
idents or the researchers involved in delivering the inter-
vention to the group allocation. However, the
researchers and study assistants who collect the data at
the different times and the biostatisticians who perform
the data analysis will be blinded.
If an outcome assessor becomes unblinded, they will
no longer collect data but will be replaced with another
trained, blinded researcher. To estimate the success of
blinding, the outcome assessors will be formally asked to
guess the allocation of the study groups including a jus-
tification ; their responses will be compared with what
would be expected by chance [21]. If data indicates that
blinding was unsuccessful, we will replace the outcome
assessor with another blinded researcher.
The PECAN intervention
The experimental complex intervention PECAN was de-
veloped according to the MRC framework, and pilot
tested in a previous project entitled JointConImprove
[10, 18, 19]. We then systematically revised, updated and
refined our logic model as well as the intervention and
implementation components according to the results
from the process evaluation of the pilot study (publica-
tion in preparation). The logical model for PECAN is
outlined in Fig. 2. As Moore and Rhiannon [22] recom-
mend, we integrated the contextual perspective in our
model [23] and involved stakeholders in the develop-
ment so that the underlying mechanisms were ad-
equately addressed. Theoretically, PECAN was guided by
the biopsychosocial model in the ICF, which provides a
comprehensive framework for conceptualizing a person’s
level of functioning as the dynamic interactions between
their health status and environmental and personal fac-
tors, which can act as facilitators or barriers [12, 24].
The PECAN intervention aims to improve activities and
participation in individuals with joint contractures by
(a) integrating the biopsychosocial model of the ICF
into daily care activities
(b) identifying and prioritising the targets for activities
and participation for each resident
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(c) identifying the barriers and facilitators to the
residents’ participation and activities
(d) implementing participation-oriented care planning,
taking the identified barriers and facilitators into
consideration.
Therefore, improvements in participation and activities
may be achieved in four ways:
(1) by improving impaired body functions and
structures to allow activities and participation
(2) by alleviating restrictions to daily activities through
a resource-oriented promotion of activities to
improve the residents’ autonomy in daily life
(3) by considering the residents’ personal factors
(4) by changing environmental factors to improve
activities and participation.
To achieve the intervention goals, we will use an
approach tailored to each individual.
Personal and environmental factors should be incorpo-
rated into each resident’s care plan and daily routine. In
planning a resident’s personal goals, individual measures
should follow a biographical approach that assesses the
individual’s motives for participation. Environmental fac-
tors can be addressed by optimising the needs-based
provision of adaptive technologies, medical aids and
physical therapy, and by integrating family members or
volunteers in organising activities during their visits.
On the organisational level, facilitators and barriers
should be identified using a checklist with predefined
criteria. In this way, the implementation of the PECAN
intervention can be reviewed in terms of (1) the adapta-
tions made to individual care plans for residents, (2) the
dissemination of the principles of the intervention to
co-workers, leaders and the public, (3) the interprofes-
sional collaborations with social care assistants, thera-
pists and social workers, and (4) the environmental
factors for the site and the surrounding area.
Implementation strategy
The implementation is based on the theory of planned
behaviour [25], since our aim is to advance the profes-
sional attitudes of the nursing home staff such that their
Fig. 2 Logic model of the PECAN concept. ICF International Classification of Functioning, Disability and Health, PECAN Participation Enabling Care
in Nursing
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professional behaviour changes. Applying the theory of
planned behaviour to predict or explain health-care pro-
fessionals’ behaviour has been successful elsewhere [26,
27]. We chose a multifaceted facilitation approach in
which we trained and supported nominated key nurses
from the nursing homes, focusing on advancing their
knowledge, attitudes and skills, and on utilising social
support from nursing staff, management and other
players. Facilitation is a concerted social process that
focuses on evidence-informed practice change [28]. It
has already been implemented effectively in nursing
homes and in primary care [29–31]. Figure 3 is an over-
view of the implementation strategy.
Kick-off meeting A kick-off meeting with the nursing
home director and the head nurse will be sched-
uled shortly after the randomisation, at which the
research team will provide detailed information about
the PECAN concept, planned tasks for the
implementation and required resources. The manage-
ment’s commitment will be documented in a written
declaration.
Facilitators’ workshop A one-day-workshop for the
nominated nurses will prepare them for their role as
knowledge facilitators and change agents for the imple-
mentation of PECAN in their nursing homes. Facilita-
tion depends upon the facilitator, who acts and enables
others to implement a practice change [28]. There
should be at least one facilitator per cluster, who will be
appointed by the head nurse. As a prerequisite, the facil-
itators must have completed at least 3 years of voca-
tional training in nursing or geriatric care.
The workshop will be run by the research team at the
relevant study centre and covers the following content:
a) information about the study and the facilitators’
future tasks
Fig. 3 Overview of the implementation approach. PECAN Participation Enabling Care in Nursing
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b) current evidence about joint contractures, including
their impact on participation, and their
development, prevention and effective treatment
c) strategies of and training in PECAN by applying the
biopsychosocial model of the ICF to identify
barriers and facilitators of the resident’s
participation.
Peer mentoring The peer mentoring includes a visit
by an interdisciplinary team of peer mentors and con-
tinuous support by telephone for peer counselling. A
study nurse from the research team at the relevant study
centre will take on a mentor role and provide regular
support to the facilitators during the intervention
period.
Peer mentor visit Our peer mentor visits are based on
the concept of nursing peer review in which the care
provided by nurses is systematically evaluated by a group
of peers [32]. This tool helps to ensure the quality of
nursing care through the application of evidence-based
principles and fosters a continous learning culture of pa-
tient safety and best practice [32]. The half-day peer
mentor visit will occur once during the intervention
period to provide the facilitators with purposeful coun-
selling and support. The head nurse and the nursing
home directors will also be invited. The research team
visiting the nursing homes will comprise an external
peer expert with experience in geriatric care for resi-
dents with joint contractures and in change manage-
ment, the mentor (study nurse) and an additional
member of the research staff.
The peer experts will provide supervision at the individ-
ual level by reviewing the care plans of two participating
residents. A structured tool will be used to assess
patient-related issues and to guide the facilitators in plan-
ning the intervention. Moreover, any calls for action at the
organisational level will be systematically reviewed using a
checklist to identify action points in the implementation
process. Finally, the next steps at the individual and organ-
isational levels will be planned together, whereby the men-
tor will support the facilitators in implementing the
PECAN intervention. Additional visits can be requested
by the facilitators, which will be discussed during the tele-
phone counselling sessions.
Additional material will be supplied, such as informa-
tion pamphlets for relatives, legal guardians and
health-care professionals. The facilitators will be given
material e.g. motivational posters that they can use to
promote the aims of PECAN in the nursing homes.
Telephone peer counselling The facilitators will receive
counselling from their mentor via regular phone calls at
least once a month, starting after the peer mentor visit
and lasting for nine months. The mentors will also be
available for further advice during regular office hours.
In each counselling session, the facilitator will give feed-
back of their experience with the implementation of the
PECAN intervention, the tasks performed in the past
weeks and their realisation of the implementation plan.
The mentors will also counsel on communication issues
within both the team and the organisation and answer
technical questions on medical aids. The mentors will also
be responsible for discussing any necessary organisational
changes identified during the peer mentor visit or the tele-
phone counselling with the nursing home managers.
In-house information event A one-day in-house infor-
mation event will be held in the nursing homes for resi-
dents, relatives, interested members of the public,
volunteers and nursing home staff including social
workers, visiting therapists, visiting physicians and advis-
ory committee members. To create awareness of the
project, we will supply written and oral information, geared
to the different target groups, about the development and
impact of joint contractures on participation, plus a basic
overview of current evidence, details about the study and
PECAN as well as suggestions for how the various
individuals can support the implementation.
Information session for nursing staff A brief informa-
tion session of 45min will be held by the research team
for the nursing staff during a regular team meeting. It will
provide information about PECAN, its aims, the tasks of
the facilitators and how the nursing staff can support the
intervention. The research team will illustrate the under-
lying principles using a short case vignette.
Facilitators’ experience exchange and training
session on collegial consultation Both PECAN and
methods of collegial consultation [33] will be practised
in a half-day training session by discussing actual cases
(case vignettes). Members of the research team will train
the facilitators on how to advise and coach their col-
leagues during the implementation. Furthermore, the
facilitators will be able to exchange their experiences
and discuss barriers and facilitators to implementation.
Modification and risk–benefit assessment
Possible benefits for the participants are improvements
in activities or participation despite existing functional
limitations due to joint contractures plus a reduction in
the risk of further joint contractures. No modification of
PECAN is planned, and no side effects, risks or compli-
cations are expected due to participation in the interven-
tion. However, possible complications will be identified
through the continuous close peer mentoring and
reacted to promptly. In addition, the facilitators will be
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encouraged to talk directly to the relevant researchers,
should problems arise. In the pilot study, there were no
relevant differences between the intervention and con-
trol group regarding potential adverse events, such as
the frequency of falls and fall-related fractures, nor was
there any relevant increase in comparison to the
baseline.
Control group
The nursing home residents in the control group will re-
ceive optimised standard care based on the usual care
plus a brief in-house presentation of 45 min for nursing
home staff, mainly nurses and additional care helpers.
The session will cover information on the study, on the
development of joint contractures, and on their rele-
vance for daily life and the social participation of the af-
fected individuals. It will also include a basic overview of
current evidence, excluding intervention-related details.
To avoid contamination between the intervention and
the control groups, the participating nursing homes will
be obliged to refrain from actively disseminating inter-
vention components to any other institutions, especially
to other nursing homes in the control group. After the
intervention period, nursing staff from the control group
are given the opportunity to attend the workshop for fa-
cilitators and to receive the educational material and
handbook free of charge.
Outcome measures
Data for outcomes and other variables will be collected
at three measurement points: at baseline before random-
isation (t0), after 6 months (t1), and after 12 months (t2).
Table 1 provides an overview of the different variables
on an individual level, which includes the ratings of the
nursing home residents. We will assess the cognitive
status of the residents at each time point to decide if the
outcome measurements will require a proxy rating,
which the nursing staff will perform.
Primary outcome
The initial objective of the project was to improve par-
ticipation in nursing home residents with joint contrac-
tures. However, the results of the pilot study suggested
that an improvement in participation is difficult to real-
ise, especially within a population undergoing cognitive
decline. Since activities and participation are related but
independent constructs with no ranking, we decided that
an improvement in any of the scales could be viewed as
success. Therefore, the selected primary outcomes assess
the nursing home residents’ participation and activities,
which are measured with the two subscales of the
ICF-based PaArticular Scales [17], a patient-centred
self-reported measure. The PaArticular Scales were de-
veloped in a previous project using item response theory
(Rasch analysis) based on a standard set of questions for
joint contractures [15]. The instrument has two inde-
pendent subscales. The participation subscale measures
the impact of joint contractures on the participation of a
person, i.e. the social perspective of functioning involv-
ing interactions with other people. It has 11 items on
topics such as community life, sports, crafts and socialis-
ing. The activities subscale measures the impact on as-
pects of life related to mobility and self-care. It has 24
items on topics such as changing and maintaining body
position, walking and moving, carrying, moving and
handling objects, dressing and eating.
The scales were developed and validated in a sample
of nursing home residents and patients in geriatric re-
habilitation who were affected by joint contractures. The
items were selected in a comprehensive standardised
Table 1 Instruments and measures at resident level
Instrument Outcome Measurement point
t0 t1 t2
Primary outcomes
PaArticular Scales, subscale participation [17] Participation X X X
PaArticular Scales, subscale activities [17] Activities X X X
Secondary outcomes
EQ-5D-5L [34, 35] Health-related quality of life X X X
Additional data sources
Medical records Clinical data X X X
DSS [36] Cognitive impairment X X X
CMAI [37, 38] Behavioural symptoms X X X
Clinical records Falls and fall-related consequences X X X
Clinical records Physical restraints X X X
CMAI Cohen–Mansfield Agitation Inventory, DSS Dementia Screening Scale, EQ-5D-5L EuroQol Five-Dimension Five-Level Instrument, t0 baseline before
randomisation, t1 6 months post-randomisation, t2 12 months post-randomisation
Nguyen et al. Trials          (2019) 20:305 Page 8 of 15
procedure in line with the suggestions for developing
ICF core sets [39, 40]. The Rasch modelling approach to
constructing scales based on items from the ICF has
been shown to be valid in other studies [41, 42]. Before
any analyses on the primary outcome are carried out,
the psychometric properties of the PaArticular Scales
will be re-evaluated in a Rasch-analysis of the data from
the pilot study.
For each subscale, the nursing home resident or, if not
possible, a proxy (nurse), assesses their existing difficul-
ties for the different items on a scale ranging from 0 for
“no problem”, 1 for “mild to moderate problem” and 2
for “severe problem” to 3 for “complete problem”. Add-
itionally, an item is assigned “C” if the difficulty can be
assigned without doubt to a cause other than the con-
tracture. For both the participation subscale and the
activity subscale, the scores are summed to give an initial
ordinal raw score. This is transformed into an interval
scaled score, ranging from 0 to 100, to allow compari-
sons at the interval level.
A mean decrease of ten points on the participation or
activity subscale of the PaArticular Scales at t2 is consid-
ered as a clinically meaningful difference in favour of the
PECAN intervention. This would represent a change
from “complete problem” to “mild/moderate/severe
problem” or from “mild/moderate/severe problem” to
“no problem” in one of the patient-relevant items. The
ten-point difference is also in line with the suggested
distribution-based methods for defining a minimally im-
portant difference as at least 1/2 of the standard devi-
ation [43], because the standard deviation in the baseline
data from our pilot study is about 14, which is below 20.
In a recent review of the test–retest reliability of
patient-centred self-reported measures for older people,
the methodological quality of the PaArticular Scales was
assessed as “fair” [44].
Secondary outcome
The secondary outcome is the nursing home residents’
quality of life. We will assess health-related quality of life
at t0, t1 and t2, using the German version of the inter-
nationally established generic instrument the European
Quality of Life Five-Dimension Five-Level Scale
(EQ-5D-5L) [34, 35]. The residents can rate their health
status using the following five dimensions: mobility,
self-care, usual activities, pain/discomfort and anxiety/
depression. Each dimension has five levels: no problems,
slight problems, moderate problems, severe problems
and extreme problems. Furthermore, a vertical visual
analogue scale (EQ-VAS score) records a resident’s
self-rated health from best to worst imaginable (range
0–100). In the corresponding proxy version, the nursing
staff will be asked to rate how they think the residents
would rate their own health-related quality of life, if they
were able to communicate it.
Additional measures
We will collect further data for descriptive purposes (see
Table 1). On an individual level, we will collect clinical
data such as length of stay at baseline. In addition, we
will collect grade of care, urinary and faecal incontin-
ence, affected joints, provision of adaptive technologies,
medical aids, physical therapy and occupational therapy
at each time point. Additional characteristics will be col-
lected from nurses’ assessments of the residents’ cogni-
tive status and behavioural symptoms that are related to
dementia.
A nurse will rate the cognitive status of each resident
during the last month of the intervention using the
Dementia Screening Scale (DSS) [36] to assess whether a
proxy rating is required. The DSS contains the dimen-
sions memory and orientation, giving a total of seven
items each with a three-point scale (never, occasionally
or always). The tallied responses result in an overall
score with a range from 0 to 14, higher values indicating
a greater degree of cognitive impairment. A proxy rating
is performed at a cut-off point of 3.
The residents’ behavioural symptoms will be deter-
mined using a modified German version [45] of the
Cohen–Mansfield Agitation Inventory (CMAI) [37, 38],
as used in previous studies [46, 47]. The inventory
consists of five symptom complexes: restlessness, verbal
agitation, handling things inappropriately, negative
attitude and aggression. Each complex is rated on a
four-point Likert scale (never, once or twice, repeatedly,
permanently) that assesses symptoms within the preced-
ing four weeks.
On a cluster level, we will record the ownership of the
nursing home (public, non-profit-organisation or pri-
vate), its location and surroundings, the number of resi-
dents, the number and size of wards, the number of
residents with joint contractures, staff mix and ratio, and
the use of strategies for dealing with joint contractures
or participation restrictions by interviewing the director
of the nursing homes or head nurse at baseline.
To document adverse events that are potentially asso-
ciated with the PECAN intervention, we will collect data
on an individual level concerning the incidence of falls,
fall-related consequences as well as the number and
types of physical restraints used.
Data collection and management
All assessments will be performed on a paper-and-pencil
basis by blinded members of the research team, who will
be thoroughly trained in the data collection procedure.
Only pseudonymised data will be collected at the study
centres in Halle (Saale) and Rosenheim, i.e. no personal
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data about the participants will be recorded or saved.
The participating nursing homes will be allocated a
pseudonymised number. To compare the outcomes from
the measurement points, each participant will be
assigned a code from a list, which will be stored separ-
ately and can be accessed only by the researchers at the
study centres. The list will never be merged with the
pseudonymised data and will be destroyed after the final
validation of the analysis data set.
After each measurement point, the paper-based pseu-
donymised data at resident level from the study centres
in Halle (Saale) and Rosenheim will be transferred to the
biostatisticians’ institution, where the data entry and
analysis will be performed by the data managers and bio-
statisticians. A copy of the questionnaires will remain
safely stored at the respective study centres.
All answer to the questionnaires will be entered into a
database and validated through double entry. The first
data entry will take place at the latest 1 month after the
different time points. Additionally, the data will be
checked for inconsistency and completeness and its
quality will be reported to the study centres.
The pseudonymised data will be stored on a secure
computer. These data will be handled in accordance
with the data protection declaration of the biometric in-
stitution. The server and all connected data arrays are in
a limited access server room that is protected by a key
card system and an alarm. The data will be encrypted
and password-protected when being transferred between
secure servers. Any hard-copy printouts, USB data ver-
sions or other removable media that are used to transfer
protected health information will be destroyed after the
transmission is complete.
Given the nature of the intervention, we do not expect
either any serious safety concerns or an early termin-
ation of the study. There is, therefore, no necessity for a
data monitoring committee. Moreover, we do not expect
any serious adverse events. Thus, no interim analysis is
planned, and there are no stopping rules for safety
issues. However, we plan to monitor the data quality in a
blinded manner every 6 months during our regular study
meetings. Data quality (e.g. proportion of missing values)
and organisational or logistic issues will be reviewed and
discussed in these meetings. In this way, any necessary
actions to improve data quality and study logistics can
be made early enough.
Statistical analysis
The primary outcomes are the nursing home residents’
participation and activity, measured with the subscales
of the ICF-based PaArticular Scales [17]. The evaluation
of the impact of joint contractures and the effect of
PECAN will be based on an intention-to-treat approach
with a significance level of 0.05, which results in a
Bonferroni-adjusted significance level of 0.025 for a single
test. The analyses will use a generalised linear mixed-effect
regression model to compare changes in the scale between
the treatment groups over a year. Each nursing home will
be given a random intercept. The analysis will be adjusted
by the individual baseline values.
Secondary analyses
The secondary outcome is the nursing home residents’
quality of life, which will be assessed at t0, t1 and t2 with
the EQ-5D-5L [34, 35]. The analyses will also use a gen-
eralised linear mixed-effect regression model with
EQ-5D-5L score changes over 1 year as the dependent
variable, adjusted by the baseline value. Each nursing
home will be given a random intercept.
The analyses of the primary and secondary outcomes
will also allow for an additional adjustment for cluster
and individual-specific confounding baseline variables
such as age, gender, length of stay and grade of care at
the individual level as well as ownership, number of resi-
dents, staff mix and ratio, and use of strategies for deal-
ing with joint contractures or participation restrictions.
Further statistical issues
At each time point, if DSS ≥ 3, the outcome measure-
ments will require a proxy rating. Sensitivity will be
ascertained by removing these proxy ratings from the
analysis. To investigate the impact of other influencing
factors on the effect of PECAN, different subgroup ana-
lyses might be done. The necessity and feasibility of dif-
ferent subgroup analyses will be considered. The impact
of missing values will be done by comparing complete
case analyses with multiple imputation analyses.
Process evaluation
The process evaluation follows the MRC guidance for
complex interventions [48]. The results will be used to
understand the implementation of PECAN, causal
mechanisms and contextual factors that influence partici-
pation, activity and quality of life [49]. Grant’s frame-
work for designing process evaluations of c-RCTs will
also be applied [49]. Along with the MRC guidance, this
framework was adapted to make it appropriate for our
study (see Fig. 4).
According to Moore et al. [48], the three focal points
(implementation, mechanisms of impact and context) as
well as their interaction with each other are crucial in a
process evaluation. For the generalisability of the results,
another central component of a process evaluation is the
recruitment of clusters [49].
When evaluating recruitment, the implementation and
the mechanisms of impact, we differentiate between the
cluster level and the individual level. For the study,
distinguishing between these levels in the process
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evaluation is meaningful because the PECAN interven-
tion is not delivered directly to the residents, but via the
cluster [49]. The aim of the PECAN intervention is to
produce behavioural changes by the nursing staff in the
clusters, which will ultimately affect the residents.
The process evaluation of the implementation con-
siders the structures, resources and processes through
which delivery succeeds [48]. This includes an assess-
ment of the quality (fidelity) and the quantity (dose) of
what was delivered and to what extent the PECAN inter-
vention has reached the clusters and individuals. The
evaluation also includes the adaptation of the PECAN
intervention by the individual clusters [48]. To evaluate
the mechanisms of impact, the intervention activities
and how the clusters and individuals interact with the
intervention activities will be considered. Additionally,
mediators, unexpected processes and their consequences
are recorded in this evaluation [48, 49].
The component context contains all the external fac-
tors that influence the delivery and the functionality of
an intervention. Contextual factors can influence the ef-
fectiveness of the intervention both indirectly by shaping
the implementation and directly by affecting the mecha-
nisms of impact [48]. The evaluation can also highlight
the relationships between the study processes and the
primary and secondary outcomes [49]. In addition, dif-
ferences in the effectiveness of the intervention at the
different nursing homes can be explored.
According to Moore et al. [48], it is more useful to
answer the most important questions (core questions)
than trying to solve every question raised by a process
evaluation. Therefore, it is necessary that the causal
assumptions substantiating the intervention are
known [48]. A mixed-methods approach will be pursued,
including quantitative and qualitative methods of data
collection and data analysis. Quantitative data will be
analysed using descriptive statistics. Qualitative data
from focus groups and semi-structured interviews will
be tape-recorded and transcribed verbatim for analysis.
These data and data from open-ended questions in the
questionnaires will be analysed using content analysis
[50] by two independent members of the research team.
The central questions in the process evaluation and
the data collection procedures are listed in Fig. 4; a
detailed overview is presented in Additional file 1.
Health economic evaluation
The objective of the health economic evaluation is to
estimate the cost-effectiveness of the PECAN interven-
tion in terms of additional costs per additional resident
who experienced a decrease of ten points on the partici-
pation or the activities subscale of the PaArticular Scales.
Moreover, a cost–utility analysis will consider the add-
itional costs required for each additional QALY induced
by the intervention.
Fig. 4 Process evaluation adapted from Grant et al. [49] for c-RCTs and from the MRC guidance [48]. c-RCT Cluster-randomised controlled trial,
MRC UK Medical Research Council, PECAN Participation Enabling Care in Nursing
Nguyen et al. Trials          (2019) 20:305 Page 11 of 15
The economic evaluation will be performed from the
perspective of the German social insurance system,
which has statutory health insurance and long-term care
insurance. Thus, an incremental cost-effectiveness ratio
(ICER) will be calculated. This is defined as the differ-
ence in costs for the intervention and the control group
divided by the difference in the number of nursing home
residents who experienced a decrease of ten points in
the participation or the activities subscale. Similarly, an
incremental cost–utility ratio (ICUR) will be derived.
This is the difference in costs divided by the difference
in QALYs.
The primary outcome of the study will serve as the ef-
fect parameter in the cost-effectiveness analysis. Utility
in the cost–utility analysis will be assessed by QALYs.
These are based on health-related quality of life, which
will be measured by the EQ-5D-5L and evaluated by a
German tariff [51] to generate utility values.
Costs will be collected during the study for
intervention-related components as well as for outcome-
related components. In detail, resource use associated
with the PECAN intervention (e.g. wage costs for the in-
structor associated with the facilitators' workshop and
the opportunity costs of the trained nurses) will be de-
rived from the study documentation. Costs explicitly as-
sociated with the study, such as data collection, will not
be considered. For outcome-related components, we will
retrospectively document for the previous 6 months the
costs of physical therapy and occupational therapy at all
three measurement points (t0, t1 and t2). Fall-related
health-care utilisation will be documented retrospect-
ively at baseline (t0) for the previous 12 months and at t1
and t2 for the previous 6 months. Furthermore, care
levels and available medical aids will be recorded at each
measurement point.
Health-care resource use due to the intervention
and other reported health-care use will be multiplied
by unit costs. Currently, there are no German guide-
lines for costing in an economic evaluation based on
standard unit costs. Hence, health-care resource use
will be valued by unit costs from published sources
and official statistics for Germany (e.g. charges and
rates from administrative databases and pharmacy
retail prices).
For the health economic analysis, mean costs as well
as cost differences between the intervention and the
control group will be calculated as cluster averages.
ICER and ICUR will be calculated and the
non-parametric bootstrap method will be employed to
generate confidence intervals around the ICER and
ICUR estimates [52, 53]. Uncertainty surrounding the
ICER will also be presented on the cost-effectiveness
plane [54, 55] and as a cost-effectiveness acceptability
curve [56, 57].
Quality assurance
The study will be planned, implemented and evaluated
in accordance with the principles of good clinical prac-
tice [58] and the Declaration of Helsinki [59]. This study
was registered with the publicly accessible German Clin-
ical Trials Register (DRKS) under the ID DRKS00015185
before any study participants were enrolled. This study
protocol will be published in a peer-reviewed journal
and it will follow the most recent Standard Protocol
Items: Recommendations for Interventional Trials
(SPIRIT) statement [21, 60] and applicable criteria from
the template for intervention description and replication
(TIDieR) [61]. The corresponding checklists are pre-
sented in Additional files 2 and 3. To ensure safety, a
detailed quality assurance plan will be developed. This
plan will contain the detailed objectives of the study
parts; will summarise the monitoring methods for data
collection, validation and reporting; will state the
methods for response monitoring; and will provide a
schedule for field audits and reporting procedures.
Standard operating procedures and an auditing plan will
also be included. Standard operating procedures will be
developed to provide the research staff with instructions
for collecting, handling, reporting and evaluating the
data. Furthermore, a scientific advisory board of at least
three experts from relevant professions will be convened
to supervise the trial.
To ensure they are widely disseminated, we will pub-
lish the main study outcomes in peer-reviewed scientific
journals and will present the results at scientific confer-
ences. All results will be reported in accordance with the
extension of the Consolidated Standards of Reporting
Trials (CONSORT) for cluster trials [62], the revised
guideline in the Criteria for Reporting the Development
and Evaluation of Complex Interventions in health care
[63] and the TIDieR checklist [61]. All trial information
will be freely available via the trial homepage (https://
bewegung-verbindet.de/english-version/). The homepage
contains general information about completed and on-
going projects as well as German and English publica-
tions, which are aimed at researchers, clinicians, nursing
staff, health-care providers and consumers.
Ethical and legal considerations
The research staff are obliged (1) to ensure that the sub-
jects involved in the research have opportunities to ad-
dress any sense of burden and (2) to maintain their
well-being. The principal investigators will inform the
ethic committees immediately of any changes in the
study protocol, of any expected or unexpected
serious events, or of the early termination of the study.
Prior to inclusion in the study, all nursing home di-
rectors, all head nurses and all available residents or
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their legal guardians will be informed orally and in
writing about the nature, objectives, expected benefits
and potential risks of the study, then given sufficient
time and opportunity to decide whether to participate
and to clarify open questions before informed consent
is obtained.
The nursing homes and residents or their legal guard-
ians will be informed that all study-related data will be
stored in pseudonymised form and will be used only for
scientific data analysis. All study data will be kept in a
locked archive for ten years at the study centres after
completion of the trial and will then be deleted. Fur-
thermore, the EU General Data Protection Regulation
will apply, and all participants will be explicitly in-
formed about their rights. In the event of any violations
of ethical standards with respect to the medical care of
the residents or research-related activities within the
study, a standardised protocol will be closely followed,
supervised and executed by the study coordinator
(MM).
Discussion
In this c-RCT, we aim to evaluate the effectiveness of
the complex PECAN intervention to improve participa-
tion and activities of older nursing home residents with
joint contractures. We will use a customised approach
to facilitate the realisation of the residents’ individual
aims for participation in their daily lives. To enable the
effective improvement of activities and participation, our
intervention includes components at an individual level
and an organisational level.
We aim to advance the nursing staff ’s professional
attitude and thus, support the implementation by
underlining the influence of contractures on participa-
tion, autonomy and consequently, on the quality of
life of impacted residents and by empowering the
staff to apply PECAN.
Due to our experiences gained from the pilot study,
we will focus specifically on improving the delivery of
the intervention to residents and nursing staff. The
rigorous process evaluation will ensure that the imple-
mentation process is supervised. It will ensure the safety
of the PECAN intervention and it will allow us to adjust
components or strategies, if necessary.
By including contextual factors at different levels in
our logic model, we will be able to collect and observe
influencing aspects systematically, e.g. new laws and
directives regarding quality indicators for nursing home
care will be included in the legal context.
We expect to see an improvement in the residents' ac-
tivities or participation or both due to the carefully de-
veloped and tested PECAN intervention and no
safety-related adverse effects. If proven successful, we
will transform the intervention protocol into a training
course for skilled nurses, which will be taught at ad-
vanced training institutes of the universities in Halle
(Saale) and Rosenheim. Our findings will provide im-
portant insights into the social participation of older
people with joint contractures.
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